StarTric
PrivateLast Round
Grant
Mar 18, 2025
Total Funding Raised
$1.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
StarTric operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Seed round in July 2024.
StarTric is a medical technology company that develops a transcatheter device for tricuspid valve repair designed to replicate the Clover surgical technique.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StarTric Comparables
Compare StarTric with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriFlo Cardiovascular Inc. | 88% | |
| CroíValve | 86% | |
| Trisol Medical | 84% |
For institutional investors. Book with your work email.
StarTric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2025 | ||||
| Seed | Jul 8, 2024 | ||||
| Accelerator | Mar 1, 2024 | ||||
| Seed | Oct 26, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
StarTric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Growth Engine | Seed, Accelerator |
| NLC Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 3012% MoM, from 78 to 2.4K.
- Mar 18, 2025
$2.7M grant awarded by the European Innovation Council.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 29, 2026
Startric Srl was named the winner of the Shark Tank cardiovascular innovation competition at the 2026 TCT Plus Middle East conference in Saudi Arabia on Sep 17th-19th '26, selected by judges from four finalists for its tricuspid valve repair system.
- attends_eventSep 29, 2026
Startric Srl has been named the winner of the Shark Tank cardiovascular innovation competition at the 2026 TCT Plus Middle East conference, held Sep 17th–19th '26 in Saudi Arabia.
For institutional investors. Book with your work email.
StarTric Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StarTric's valuation, stock price, and market status.
Is StarTric a public or private company?
StarTric is a private company.
What is the current stock price of StarTric?
StarTric is a private company, so its shares have no public market price. Caplight tracks StarTric's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StarTric worth (valuation)?
Valuation information for StarTric is not publicly available.
Can I buy StarTric stock?
StarTric shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StarTric's last funding round?
StarTric's most recent funding round was Grant on March 18, 2025.
Who are the main investors in StarTric?
Key investors in StarTric include European Innovation Council Fund, Growth Engine, NLC Health Ventures.
Will StarTric IPO soon?
No public IPO plans have been announced for StarTric.
How can I track StarTric secondary market activity?
Caplight tracks bids, offers, and trades in StarTric's shares on secondary markets.